Filing Details

Accession Number:
0001021561-21-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-04 19:19:39
Reporting Period:
2021-01-04
Accepted Time:
2021-01-04 19:19:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1021561 Nu Skin Enterprises Inc. NUS Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 870565309
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1231132 Matthew D Dorny C/O Nu Skin Enterprises, Inc.
75 West Center Street
Provo UT 84601
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-01-04 6,200 $30.63 50,573 No 4 M Direct
Class A Common Stock Disposition 2021-01-04 5,365 $54.95 45,208 No 4 S Direct
Class A Common Stock Disposition 2021-01-04 835 $55.48 44,373 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (Right to Buy) Disposition 2021-01-04 6,200 $0.00 6,200 $30.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,800 2023-03-02 No 4 M Direct
Footnotes
  1. Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.30 to $55.27, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.34 to $55.68, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
  4. Currently exercisable in full.